Viewpoint: Beware a fraudulent ‘October vaccine surprise’ as Trump maneuvers to win re-election

x
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Oct. 23, 2020, 9 a.m., with 10 days before the election, Fox New releases a poll showing President Trump trailing Joe Biden by eight percentage points.

Oct. 23, 2020, 3 p.m., at a hastily convened news conference, President Trump announces that the Food and Drug Administration has just issued an Emergency Use Authorization for a coronavirus vaccine. Mr. Trump declares victory over Covid-19, demands that all businesses reopen immediately and predicts a rapid economic recovery.

Given how this president has behaved, this incredibly dangerous scenario is not far-fetched. In a desperate search for a political boost, he could release a coronavirus vaccine before it had been thoroughly tested and shown to be safe and effective.

There are 123 candidate Covid-19 vaccines in development, and 10 are in human trials. Many have not even been tested, or only perfunctorily tested, in animals. In July, the National Institutes of Health is planning to begin randomized phase III trials to test whether some of the 10 vaccines prevent infection with coronavirus. Some pharmaceutical companies are planning to start their own trials at about the same time.

Related article:  Could we functionally cure HIV through gene editing?

Thousands of Americans have already died as Donald Trump has perpetually postponed effective public health interventions and made poor therapeutic recommendations. We must be on alert to prevent him from corrupting the rigorous assessment of safety and effectiveness of Covid-19 vaccines in order to pull an October vaccine surprise to try to win re-election.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend